Abstract
The three-dimensional (3D) bioprinting technology has progressed tremendously over the past decade. By controlling the size, shape, and architecture of the bioprinted constructs, 3D bioprinting allows for the fabrication of tissue/organ-like constructs with strong structural–functional similarity with their in vivo counterparts at high fidelity. The bioink, a blend of biomaterials and living cells possessing both high biocompatibility and printability, is a critical component of bioprinting. In particular, gelatin methacryloyl (GelMA) has shown its potential as a viable bioink material due to its suitable biocompatibility and readily tunable physicochemical properties. Current GelMA-based bioinks and relevant bioprinting strategies for GelMA bioprinting are briefly reviewed.
Original language | English (US) |
---|---|
Pages (from-to) | 215-224 |
Number of pages | 10 |
Journal | Bio-Design and Manufacturing |
Volume | 1 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2018 |
All Science Journal Classification (ASJC) codes
- Biotechnology
- Biomedical Engineering
- Materials Science (miscellaneous)
- Industrial and Manufacturing Engineering